Skip to main content
OpenTrials

Clinical trial condition

Langerhans Cell Histiocytosis

Explore clinical trials studying Langerhans Cell Histiocytosis. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Langerhans Cell Histiocytosis trial results

Recruiting

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

NCT02670707

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Stanford Children's Hospital, Lucile Packard Children's Hospital Palo Alto, California, United States
  • Rady Children's Hospital - San Diego San Diego, California, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH

NCT05997602

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Children's Hospital Affiliated to the Capital Institute of Pediatrics Beijing, Beijing Municipality, China
  • Children's Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Sun Yat-Sen Memorial Hpsipital,Sun Yat-Sen Unniversity Guangzhou, Guangdong, China
View Trial Details
Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

NCT03155620

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details
Active, not recruiting

Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders

NCT02425904

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 15 locations
View Trial Details
Active, not recruiting

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

NCT02205762

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

NCT03220035

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +67 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details

Related conditions